Search

Search Constraints

You searched for: Author/Creator Cid, M.C.

Search Results

1. FRI0232 Treatment with angiotensin II receptor-blockers is associated with lower relapse rate and reduced duration of treatment in patients with giant cell arteritis. (23rd January 2014)

2. FRI0237 Outcome of aortic involvement in giant cell arteritis (GCA) after 1-year follow-up: Prospective study using computed tompography angiography (CTA). (23rd January 2014)

3. FRI0361 The Extension of Inflammatory Infiltrates or Intimal Hyperplasia in Temporal Arteries Do Not Significantly Predict CTA-Detection of Aortic Thickening in Newly-Diagnosed Patients with biopsy-proven Giant-Cell Arteritis. (15th July 2016)

4. FRI0477 Outcome of Large-Vessel Involvement in GIANT Cell Arteritis after 1-Year of Glucocorticoid Treatment: Prospective Study Using Computed Tompography Angiography. (10th June 2014)

5. FRI0493 Pet/ct in patients with giant cell arteritis after 1 year of treatment with tocilizumab plus prednisone taper or only prednisone taper. (12th June 2018)

6. OP0237 The Use of Positron Emission Tomography (PET) in Patients with Giant Cell Arteritis (GCA): Analysis of Data from the Diagnostic and Classification Criteria for Vasculitis (DCVAS) Study. (9th June 2015)

7. SAT0291 Serum Osteopontin in GIANT Cell Arteritis: Abiomarker Associated with Systemic Inflammatory Response and Relapsing Course. (10th June 2014)

8. SAT0353 Relationship between Disruption of The Muscular Layer in Temporal Artery Biopsies of GCA Patients and The Development of Aortic Dilatation/aneurysm during Follow-Up. (15th July 2016)

9. SAT0531 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the giacta trial. (12th June 2018)

10. SAT0535 Eular 2018 core set of data to be collected in giant cell arteritis registries and databases viewpoints from a eular task force. (12th June 2018)